Vitamin D Level Between Calcium-Phosphorus Homeostasis and Immune System: New Perspective in Osteoporosis.

Bonjour P, Clark P, Cooper C, Dawson-Hughes B, De Laet C, Delmas P, et al. WHO scientific group on the assessment of osteoporosis at primary health care level. Summary meeting report. 2004. Brussels, Belgium, 5–7 May 2004.

Van den Bergh JP, van Geel TA, Geusens PP. Osteoporosis, frailty and fracture: implications for case finding and therapy. Nat Rev Rheumatol. 2012;8:163–72.

pubmed: 22249162 doi: 10.1038/nrrheum.2011.217

Fini M, Salamanna F, Veronesi F, Torricelli P, Nicolini A, Benedicenti S, et al. Role of obesity, alcohol and smoking on bone health. Front Biosci (Elite Ed). 2012;4:2686–706.

Engelke K, Gluer CC. Quality and performance measures in bone densitometry. I. Errors and diagnosis. Osteoporos Int. 2006;17:1283–92.

pubmed: 16821003 doi: 10.1007/s00198-005-0039-0

Gluer CC, Lu Y, Engelke K. Quality and performance measures in bone densitometry. II. Fracture risk. Osteoporos Int. 2006;17:1449–58.

pubmed: 16821004 doi: 10.1007/s00198-005-0038-1

Blake GM, Fogelman I. Role of dual-energy X-ray absorptiometry in the diagnosis and treatment of osteoporosis. J Clin Densitom. 2007;10:102–10.

pubmed: 17289532 doi: 10.1016/j.jocd.2006.11.001

Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24:23–57.

pubmed: 23079689 doi: 10.1007/s00198-012-2074-y

Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. National osteoporosis foundation. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25:2359–81.

pubmed: 25182228 pmcid: 4176573 doi: 10.1007/s00198-014-2794-2

Lentle B, Cheung AM, Hanley DA, Leslie WD, Lyons D, Papaioannou A, et al. Scientific Advisory Council of Osteoporosis Canada. Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can Assoc Radiol J. 2011;62:243–50.

pubmed: 21852066 pmcid: 5101067 doi: 10.1016/j.carj.2011.05.001

Lau EMC, Sambrook P, Seeman E, Leong KH, Leung PC, Delmas P. Guidelines for diagnosing, prevention and treatment of osteoporosis in Asia. APLAR J Rheumatol. 2006;9:24–36.

doi: 10.1111/j.1479-8077.2006.00161.x

Al-Saleh Y, Sulimani R, Sabico S, Raef H, Fouda M, Alshahrani F, et al. Guidelines for osteoporosis in Saudi Arabia: recommendations from the Saudi Osteoporosis Society. Ann Saudi Med. 2015;35:1–12.

pubmed: 26142931 pmcid: 6152549 doi: 10.5144/0256-4947.2015.1

Maalouf G, Gannagé-Yared MH, Ezzedine J, Larijani B, Badawi S, Rached A, et al. Middle East and North Africa consensus on osteoporosis. J Musculoskelet Neuronal Interact. 2007;7:131–43.

pubmed: 17627082

Pecina JL, Romanovsky L, Merry SP, Kennel KA, Thacher TD. Comparison of clinical risk tools for predicting osteoporosis in women ages 50–64. J Am Board Fam Med. 2016;29:233–9.

pubmed: 26957380 doi: 10.3122/jabfm.2016.02.150237

Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J. The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int. 2000;11:S2–S17.

pubmed: 11193237 doi: 10.1007/s001980070002

Johnell O, Oden A, De Laet C, Garnero P, Delmas PD, Kanis JA. Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int. 2002;13:523–6.

pubmed: 12111011 doi: 10.1007/s001980200068

Adami S, Bertoldo F, Brandi ML, Cepollaro C, Filipponi P, Fiore E, et al. Società Italiana dell’Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro. Guidelines for the diagnosis, prevention and treatment of osteoporosis. Reumatismo. 2009;61:260–84.

pubmed: 20143003

Nordin BE, Morris HA. Osteoporosis and vitamin D. J Cell Biochem. 1992;49:19–25.

pubmed: 1644849 doi: 10.1002/jcb.240490105

Richy F, Schacht E, Bruyere O, Ethgen O, Gourlay M, Reginster JY. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis. Calcif Tissue Int. 2005;76:176–86.

pubmed: 15692726 doi: 10.1007/s00223-004-0005-4

Ström O, Borgstrom F, Kanis JA, Compston JE, Cooper C, McCloskey E, et al. Osteoporosis: burden, health care provision and opportunities in the EU. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2011;6:59–155. doi: 10.1007/s11657-011-0060-1 .

doi: 10.1007/s11657-011-0060-1 pubmed: 22886101

Weaver CM, Alexander DD, Boushey CJ, Dawson-Hughes B, Lappe JM, LeBoff MS, et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016;27:367–76.

pubmed: 26510847 doi: 10.1007/s00198-015-3386-5

Brannon PM, Yetley EA, Bailey RL, Picciano MF. Vitamin D and health in the 21st century: an update. Am J Clin Nutr. 2008;88:483S–90S.

pubmed: 18689388 doi: 10.1093/ajcn/88.2.483S

Wöbke TK, Sorg BL, Steinhilber D. Vitamin D in inflammatory diseases. Front Physiol. 2014;5:244.

pubmed: 25071589 pmcid: 4078458

Lagishetty V, Liu NQ, Hewison M. Vitamin D metabolism and innate immunity. Mol Cell Endocrinol. 2011;347:97–105.

pubmed: 21664425 pmcid: 3200473 doi: 10.1016/j.mce.2011.04.015

Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab. 2005;16:261–6.

pubmed: 15996876 doi: 10.1016/j.tem.2005.06.004

Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, et al. Multiple genetic loci for bone mineral density and fractures. N Engl J Med. 2008;358:2355–65.

pubmed: 18445777 doi: 10.1056/NEJMoa0801197

Holick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science. 1980;210:203–5.

pubmed: 6251551 doi: 10.1126/science.6251551

Mac Laughlin JA, Anderson RR, Holick MF. Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science. 1982;216:1001–3.

pubmed: 6281884 doi: 10.1126/science.6281884

Lehmann B, Meurer M. Vitamin D metabolism. Dermatol Ther. 2010;23:2–12.

pubmed: 20136904 doi: 10.1111/j.1529-8019.2009.01286.x

Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci. 2004;29:664–73.

pubmed: 15544953 doi: 10.1016/j.tibs.2004.10.005

Ohyama Y, Yamasaki T. Eight cytochrome P450S catalyze vitamin D metabolism. Front Biosci. 2005;10:608–19.

Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88:582S–6S.

pubmed: 18689406 doi: 10.1093/ajcn/88.2.582S

Holick MF. Vitamin D, deficiency. N Engl J Med. 2007;357:266–81.

pubmed: 17634462 doi: 10.1056/NEJMra070553

Heaney RP. Assessing vitamin D status. Curr Opin Clin Nutr Metab Care. 2011;14:440–4.

pubmed: 21832900 doi: 10.1097/MCO.0b013e328348ed85

Martin A, David V, Quarles LD. Regulation and function of the fgf23/klotho endocrine pathways. Physiol Rev. 2012;92:131–55.

pubmed: 22298654 doi: 10.1152/physrev.00002.2011

Henry HL. The 25(OH)D3/1α,25(OH)2D3-24R-hydroxylase: a catabolic or biosynthetic enzyme? Steroids. 2001;66:391–8.

pubmed: 11179748 doi: 10.1016/S0039-128X(00)00158-6

Henry HL. Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab. 2011;25:531–41.

pubmed: 21872796 doi: 10.1016/j.beem.2011.05.003

Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80:1717S–20S.

pubmed: 15585793 doi: 10.1093/ajcn/80.6.1717S

Chen J, Lobachev KS, Grindel BJ, Farach-Carson MC, Hyzy SL, El-Baradie KB, et al. Chaperone properties of pdia3 participate in rapid membrane actions of 1α,25-dihydroxyvitamin D3. Mol Endocrinol. 2013;27:1065–77.

pubmed: 23660595 pmcid: 5415245 doi: 10.1210/me.2012-1277

Holick MF, Schnoes HK, DeLuca HF, Gray RW, Boyle IT, Suda T. Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney. Biochemistry. 1972;11:4251–5.

pubmed: 4342902 doi: 10.1021/bi00773a009

Kumar R, Schnoes HK, DeLuca HF. Rat intestinal 25-hydroxyvitamin D3- and 1α,25-dihydroxyvitamin D3-24-hydroxylase. J Biol Chem. 1978;253:3804–9.

pubmed: 649607 doi: 10.1016/S0021-9258(17)34760-9

Halloran BP, Castro ME. Vitamin D kinetics in vivo: effect of 1, 25-dihydroxyvitamin D administration. Am J Physiol. 1989;256:E686–91.

pubmed: 2785765

Clements MR, Davies M, Hayes ME, Hickey CD, Lumb GA, Mawer EB, et al. The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency. Clin Endocrinol. 1992;37:17–27.

doi: 10.1111/j.1365-2265.1992.tb02278.x

Akeno N, Saikatsu S, Kimura S, Horiuchi N. Induction of vitamin D 24-hydroxylase messenger RNA and activity by 22-oxacalcitriol in mouse kidney and duodenum. Possible role in decrease of plasma 1α,25-dihydroxyvitamin D3. Biochem Pharmacol. 1994;48:2081–90.

pubmed: 7802698 doi: 10.1016/0006-2952(94)90508-8

Demay MB, Gerardi JM, DeLuca HF, Kronenberg HM. DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1990;87:369–73.

pubmed: 2153298 pmcid: 53265 doi: 10.1073/pnas.87.1.369

Holick MF. Vitamin D, status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19:73–8.

pubmed: 18329892 doi: 10.1016/j.annepidem.2007.12.001

Zierold C, Darwish HM, DeLuca HF. Identification of a vitamin D-response element in the rat calcidiol (25-hydroxyvitamin D3) 24-hydroxylase gene. Proc Natl Acad Sci U S A. 1994;91:900–2.

pubmed: 8302863 pmcid: 521420 doi: 10.1073/pnas.91.3.900

Zierold C, Darwish HM, DeLuca HF. Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J Biol Chem. 1995;270:1675–8.

pubmed: 7829502 doi: 10.1074/jbc.270.4.1675

Darwish HM, DeLuca HF. Recent advances in the molecular biology of vitamin D action. Prog Nucleic Acid Res Mol Biol. 1996;53:321–44.

pubmed: 8650307 doi: 10.1016/S0079-6603(08)60149-X

Ozono K, Liao J, Kerner SA, Scott RA, Pike JW. The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J Biol Chem. 1990;265:21881–8.

pubmed: 2174889 doi: 10.1016/S0021-9258(18)45821-8

Nishikawa J, Matsumoto M, Sakoda K, Kitaura M, Imagawa M, Nishihara T. Vitamin D receptor zinc finger region binds to a direct repeat as a dimer and discriminates the spacing number between each half-site. J Biol Chem. 1993;268:19739–43.

pubmed: 8396146 doi: 10.1016/S0021-9258(19)36576-7

Kim MS, Fujiki R, Kitagawa H, Kato S. 1alpha,25(OH)2D3-induced DNA methylation suppresses the human CYP27B1 gene. Mol Cell Endocrinol. 2007;265–266:168–73.

pubmed: 17250953 doi: 10.1016/j.mce.2006.12.014

Kim MS, Fujiki R, Murayama A, Kitagawa H, Yamaoka K, Yamamoto Y, et al. 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Mol Endocrinol. 2007;21:334–42.

pubmed: 17095575 doi: 10.1210/me.2006-0231

Kitazawa S, Kajimoto K, Kondo T, Kitazawa R. Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter. J Cell Biochem. 2003;89:771–7.

pubmed: 12858342 doi: 10.1002/jcb.10567

Jones G, DeLuca HF. HPLC of vitamin D and its metabolites. In: Makin HLJ, Newton R, editors. High performance liquid chromatography and its application to endocrinology, Monographs on endocrinology, vol. 30. Berlin: Springer; 1988. p. 95–139.

doi: 10.1007/978-3-642-83467-7_4

Brown EM, Pollak M, Hebert SC. The extracellular calcium-sensing receptor: its role in health and disease. Annu Rev Med. 1998;49:15–29.

pubmed: 9509247 doi: 10.1146/annurev.med.49.1.15

Jones G, Strugnell S, De Luca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev. 1998;78:1193–231.

pubmed: 9790574 doi: 10.1152/physrev.1998.78.4.1193

Suda T, Takahashi N, Abe E. Role of vitamin D in bone resorption. J Cell Biochem. 1992;49:53–8.

pubmed: 1644855 doi: 10.1002/jcb.240490110

Suda T, Ueno K, Fujii K, Shinki T. Vitamin D and bone. J Cell Biochem. 2003;88:2259–66.

doi: 10.1002/jcb.10331

Redmond J, Jarjou LM, Zhou B, Prentice A, Schoenmakers I. Ethnic differences in calcium, phosphate and bone metabolism. Proc Nutr Soc. 2014;73:340–51.

pubmed: 24621477 pmcid: 3981475 doi: 10.1017/S0029665114000068

Kinyamu HK, Gallagher JC, Prahl JM, DeLuca HF, Petranick KM, Lanspa SJ. Association between intestinal vitamin D receptor, calcium absorption, and serum 1,25-dihydroxyvitamin D in normal young and elderly women. J Bone Miner Res. 1997;12:922–8.

pubmed: 9169351 doi: 10.1359/jbmr.1997.12.6.922

Levine BS, Singer FR, Bryce GF, Mallon JP, Miller ON, Coburn JW. Pharmacokinetics and biologic effects of calcitriol in normal humans. J Lab Clin Med. 1985;105:239–46.

pubmed: 3838330

Aranow C. Vitamin D, and the immune system. J Investig Med. 2011;59:881–6.

pubmed: 21527855 pmcid: 3166406 doi: 10.2310/JIM.0b013e31821b8755

Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013;5:2502–21.

pubmed: 23857223 pmcid: 3738984 doi: 10.3390/nu5072502

Loi F, Córdova LA, Pajarinen J, Lin TH, Yao Z, Goodman SB. Inflammation, fracture and bone repair. Bone. 2016;86:119–30.

pubmed: 26946132 pmcid: 4833637 doi: 10.1016/j.bone.2016.02.020

Rigby WF, Waugh MG. Decreased accessory cell function and costimulatory activity by 1,25-dihydroxyvitamin D3-treated monocytes. Arthritis Rheum. 1992;35:110–9.

pubmed: 1370618 doi: 10.1002/art.1780350117

Adorini L, Penna G, Giarratana N, Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem. 2003;88:227–33.

pubmed: 12520519 doi: 10.1002/jcb.10340

Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419–26.

pubmed: 17898760 doi: 10.1038/nature06175

Lemire JM, Adams JS, Sakai R, Jordan SC. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest. 1984;74:657–61.

pubmed: 6611355 pmcid: 370520 doi: 10.1172/JCI111465

Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179:1634–47.

pubmed: 17641030 doi: 10.4049/jimmunol.179.3.1634

Lemire JMM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr. 1995;125:1704S–8S.

pubmed: 7782931

Giulietti A, Gysemans C, Stoffels K, van Etten E, Decallonne B, Overbergh L, et al. Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia. 2004;47:451–62.

pubmed: 14758446 doi: 10.1007/s00125-004-1329-3

Cantorna MT. Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc. 2011;69:286–9.

doi: 10.1017/S0029665110001722

Baeke F, Korf H, Overbergh L, Verstuyf A, Thorrez L, van Lommel L, et al. The vitamin D analog, TX527, promotes a human CD4+ CD25high CD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J Immunol. 2011;186:132–42.

pubmed: 21131424 doi: 10.4049/jimmunol.1000695

Palmer MT, Lee YK, Maynard CL, Oliver JR, Bikle DD, Jetten AM, et al. Lineage-specific effects of 1,25-dihydroxyvitamin D3 on the development of effector CD4 T cells. J Biol Chem. 2011;286:997–1004.

pubmed: 21047796 doi: 10.1074/jbc.M110.163790

Van Belle TL, Gysemans C, Mathieu C. Vitamin D in autoimmune, infectious and allergic diseases: a vital player? Best Pract Res Clin Endocrinol Metab. 2011;25:617–32.

pubmed: 21872803 doi: 10.1016/j.beem.2011.04.009

Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine. 2015;72:146–53.

pubmed: 25647269 doi: 10.1016/j.cyto.2014.12.027

Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009;183:5458–67.

pubmed: 19843932 doi: 10.4049/jimmunol.0803217

Joshi S, Pantalena L, Liu XK, Sarah L, Liu H, Rohowsky-kochan C, et al. 1,25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol. 2011;31:3653–69.

pubmed: 21746882 pmcid: 3165548 doi: 10.1128/MCB.05020-11

Penna G, Amuchastegui S, Cossetti C, Aquilano F, Mariani R, Sanvito F, et al. Diabetic mice by the vitamin D receptor agonist elocalcitol. J Immunol. 2006;177:8504–11.

pubmed: 17142748 doi: 10.4049/jimmunol.177.12.8504

Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, Sozzani S, et al. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol. 2007;178:145–53.

pubmed: 17182549 doi: 10.4049/jimmunol.178.1.145

Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008;8:685–98.

pubmed: 19172691 pmcid: 2906676 doi: 10.1038/nri2378

Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10:482–96.

pubmed: 20427238 doi: 10.1016/j.coph.2010.04.001

Ferreira GB, van Etten E, Verstuyf A, Waer M, Overbergh L, Gysemans C, et al. 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. Diabetes Metab Res Rev. 2011;27:933–41.

pubmed: 22069288 doi: 10.1002/dmrr.1275

Müller K, Diamant M, Bendtzen K. Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3. Immunol Lett. 1991;28:115–20.

pubmed: 1885209 doi: 10.1016/0165-2478(91)90108-M

Matheu V, Back O, Mondoc E, Issazadeh-Navikas S. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J Allergy Clin Immunol. 2003;112:585–92.

pubmed: 13679819 doi: 10.1016/S0091-6749(03)01855-4

Rudensky AY. Regulatory T, cells and foxP3. Immunol Rev. 2011;241:260–8.

pubmed: 21488902 pmcid: 3077798 doi: 10.1111/j.1600-065X.2011.01018.x

Wang T, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909–12.

pubmed: 15322146 doi: 10.4049/jimmunol.173.5.2909

Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005;19:1067–77.

pubmed: 15985530 doi: 10.1096/fj.04-3284com

White JH. Vitamin D, metabolism and signaling in the immune system. Rev Endocr Metab Disord. 2012;13:21–9.

pubmed: 21845364 doi: 10.1007/s11154-011-9195-z

Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–3.

pubmed: 16497887 doi: 10.1126/science.1123933

Edfeldt K, Liu PT, Chun R, Fabri M, Schenk M, Wheelwright M, et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A. 2010;107:22593–8.

pubmed: 21149724 pmcid: 3012480 doi: 10.1073/pnas.1011624108

Boyce BF, Xiu Y, Li J, Xing L, Yao Z. NF-kB-mediated regulation of osteoclastogenesis. Endocrinol Metab. 2015;30:35–44.

doi: 10.3803/EnM.2015.30.1.35

Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004;116:634–9.

pubmed: 15093761 doi: 10.1016/j.amjmed.2003.12.029

Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16:713–6.

pubmed: 15776217 doi: 10.1007/s00198-005-1867-7

Stone K, Bauer DC, Black DM, Sklarin P, Ensrud KE, Cummings SR. Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1998;13:1167–74.

pubmed: 9661081 doi: 10.1359/jbmr.1998.13.7.1167

Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168:1174–80.

pubmed: 18541825 pmcid: 3719391 doi: 10.1001/archinte.168.11.1174

Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629–37.

pubmed: 18695076 pmcid: 2677029 doi: 10.1001/archinte.168.15.1629

Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340–9.

pubmed: 18574092 doi: 10.1001/archinte.168.12.1340

Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–11.

pubmed: 18180395 doi: 10.1161/CIRCULATIONAHA.107.706127

Looker AC, Mussolino ME. Serum 25-hydroxyvitamin D and hip fracture risk in older US white adults. J Bone Miner Res. 2008;23:143–50.

pubmed: 17907920 doi: 10.1359/jbmr.071003

De Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, Siscovick DS. 25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol. 2009;20:1805–12.

pubmed: 19443637 pmcid: 2723983 doi: 10.1681/ASN.2008111157

Cauley JA, Lacroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008;149:242–50.

pubmed: 18711154 pmcid: 2743412 doi: 10.7326/0003-4819-149-4-200808190-00005

Rosen CJ. Clinical practice: vitamin D insufficiency. N Engl J Med. 2011;364:248–54.

pubmed: 21247315 doi: 10.1056/NEJMcp1009570

De Boer IH, Levin GP, Robinson-Cohen C, Biggs ML, Hoofnagle AN, Siscovick DS, et al. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community based population of older adults: a cohort study. Ann Intern Med. 2012;156:627–34.

pubmed: 22547472 pmcid: 3632351 doi: 10.7326/0003-4819-156-9-201205010-00004

Buehring B, Viswanathan R, Binkley N, Busse W. Glucocorticoid-induced osteoporosis: an update on effects and management. J Allergy Clin Immunol. 2013;132:1019–30.

pubmed: 24176682 doi: 10.1016/j.jaci.2013.08.040

Adachi JD, Olszynski WP, Hanley DA, Hodsman AB, Kendler DL, Siminoski KG, et al. Management of corticosteroid-induced osteoporosis. Semin Arthritis Rheum. 2000;29:228–51.

pubmed: 10707991 doi: 10.1016/S0049-0172(00)80011-6

Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007;66:1137–42.

pubmed: 17557889 pmcid: 1955167 doi: 10.1136/ard.2007.069831

Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98–107.

pubmed: 21233852 doi: 10.1038/nri2925

Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology. 1986;119:84–90.

pubmed: 3013599 doi: 10.1210/endo-119-1-84

Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209:823–5.

pubmed: 6250216 doi: 10.1126/science.6250216

Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79:820–5.

pubmed: 15113720 doi: 10.1093/ajcn/79.5.820

Schwartz AV. Diabetes mellitus: does it affect bone? Calcif Tissue Int. 2003;73:515–9.

pubmed: 14517715 doi: 10.1007/s00223-003-0023-7

Lecka-Czernik B. Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis. Curr Osteoporos Rep. 2010;8:178–84.

pubmed: 20809203 pmcid: 2947013 doi: 10.1007/s11914-010-0027-y

García-Hernández A, Arzate H, Gil-Chavarría I, Rojo R, Moreno-Fierros L. High glucose concentrations alter the biomineralization process in human osteoblastic cells. Bone. 2012;50:276–88.

pubmed: 22086137 doi: 10.1016/j.bone.2011.10.032

Al-Shoumer KA, Al-Essa TM. Is there a relationship between vitamin D with insulin resistance and diabetes mellitus? World J Diabetes. 2015;6:1057–64.

pubmed: 26240702 pmcid: 4515445 doi: 10.4239/wjd.v6.i8.1057

Flores M. A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus? Nutr Res Rev. 2005;18:175–82.

pubmed: 19079903 doi: 10.1079/NRR2005104

de Courten B, Mousa A, Naderpoor N, Teede H, de Courten MP, Scragg R. Vitamin D supplementation for the prevention of type 2 diabetes in overweight adults: study protocol for a randomized controlled trial. Trials. 2015;16:335.

pubmed: 26246241 pmcid: 4527336 doi: 10.1186/s13063-015-0851-6

Sarkar M, Bhardwaj R, Madabhavi I, Khatana J. Osteoporosis in chronic obstructive pulmonary disease. Clin Med Insights Circ Respir Pulm Med. 2015;9:5–21.

pubmed: 25788838 pmcid: 4358421 doi: 10.4137/CCRPM.S22803

Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey. Chest. 2005;128:3792–8.

pubmed: 16354847 doi: 10.1378/chest.128.6.3792

Heulens N, Korf H, Janssens W. Innate immune modulation in chronic obstructive pulmonary disease: moving closer toward vitamin D therapy. J Pharmacol Exp Ther. 2015;353:360–8.

pubmed: 25755208 doi: 10.1124/jpet.115.223032

Romme EA, Rutten EP, Smeenk FW, Spruit MA, Menheere PP, Wouters EF. Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann Med. 2013;45:91–6.

pubmed: 22462562 doi: 10.3109/07853890.2012.671536

Heidari B, Javadian Y, Monadi M, Dankob Y, Firouzjahi A. Vitamin D status and distribution in patients with chronic obstructive pulmonary disease versus healthy controls. Caspian J Intern Med. 2015;6:93–7.

pubmed: 26221507 pmcid: 4478458

Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung DY. Vitamin D levels, lung function and steroid response in adult asthma. Am J Respir Crit Care Med. 2010;181:699–704.

pubmed: 20075384 pmcid: 2868500 doi: 10.1164/rccm.200911-1710OC

Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69–87.

pubmed: 24971027 pmcid: 4070857

Hong Q, Xu J, Xu S, Lian L, Zhang M, Ding C. Associations between serum 25-hydroxyvitamin D and disease activity, inflammatory cytokines and bone loss in patients with rheumatoid arthritis. Rheumatology (Oxford). 2014;53:1994–2001.

pubmed: 24907153 doi: 10.1093/rheumatology/keu173

Hoes JN, Bultink IE, Lems WF. Management of osteoporosis in rheumatoid arthritis patients. Expert Opin Pharmacother. 2015;16:559–71.

pubmed: 25626121 doi: 10.1517/14656566.2015.997709

Varenna M, Manara M, Cantatore FP, Del Puente A, Di Munno O, Malavolta N, et al. Determinants and effects of vitamin D supplementation on serum 25-hydroxy-vitamin D levels in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2012;30:714–9.

pubmed: 22766134

Magrey M, Khan MA. Osteoporosis in ankylosing spondylitis. Curr Rheumatol Rep. 2010;12:332–6.

pubmed: 20680529 doi: 10.1007/s11926-010-0122-1

Cai G, Wang L, Fan D, Xin L, Liu L, Hu Y, et al. Vitamin D in ankylosing spondylitis: review and meta-analysis. Clin Chim Acta. 2015;438:316–22.

pubmed: 25199851 doi: 10.1016/j.cca.2014.08.040

Horowitz MC, Bothwell AL, Hesslein DG, Pflugh DL, Schatz DG. B cells and osteoblast and osteoclast development. Immunol Rev. 2005;208:141–53.

pubmed: 16313346 doi: 10.1111/j.0105-2896.2005.00328.x

Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A. 1993;90:11924–8.

pubmed: 8265649 pmcid: 48097 doi: 10.1073/pnas.90.24.11924

Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone. 1999;25:255–9.

pubmed: 10495128 doi: 10.1016/S8756-3282(99)00162-3

Zaiss MM, Axmann R, Zwerina J, Polzer K, Gückel E, Skapenko A, et al. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum. 2007;56:4104–12.

pubmed: 18050211 doi: 10.1002/art.23138

Ma L, Makino Y, Yamaza H, Akiyama K, Hoshino Y, Song G, et al. Cryopreserved dental pulp tissues of exfoliated deciduous teeth is a feasible stem cell resource for regenerative medicine. PLoS One. 2012;7:e51777.

pubmed: 23251621 pmcid: 3522596 doi: 10.1371/journal.pone.0051777

Tyagi AM, Mansoori MN, Srivastava K, Khan MP, Kureel J, Dixit M, et al. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies. J Bone Miner Res. 2014;29:1981–92.

pubmed: 24677326 doi: 10.1002/jbmr.2228

Gonçalves-Zillo TO, Pugliese LS, Sales VM, Mori MA, Squaiella-Baptistão CC, Longo-Maugéri IM, et al. Increased bone loss and amount of osteoclasts in kinin B1 receptor knockout mice. J Clin Periodontol. 2013;40:653–60.

pubmed: 23534940 doi: 10.1111/jcpe.12097

Yap KS, Morand EF. Vitamin D and systemic lupus erythematosus: continued evolution. Int J Rheum Dis. 2015;18:242–9.

pubmed: 25522756 doi: 10.1111/1756-185X.12489

Sioka C, Kyritsis AP, Fotopoulos A. Multiple sclerosis, osteoporosis, and vitamin D. J Neurol Sci. 2009;287:1–6.

pubmed: 19800081 doi: 10.1016/j.jns.2009.09.012

Olsson A, Oturai DB, Sørensen PS, Oturai PS, Oturai AB. Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis. Mult Scler. 2015;21:1557–65.

pubmed: 25623251 doi: 10.1177/1352458514566417

Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31:48–54.

pubmed: 21310306 doi: 10.1016/j.nutres.2010.12.001

Grethen E, McClintock R, Gupta CE, Jones R, Cacucci BM, Diaz D, et al. Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab. 2011;96:1320–6.

pubmed: 21325456 pmcid: 3203623 doi: 10.1210/jc.2010-2202

Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;19:951–60.

Song Q, Sergeev IN. Calcium and vitamin D in obesity. Nutr Res Rev. 2012;25:130–41.

pubmed: 22588363 doi: 10.1017/S0954422412000029

Marcotorchino J, Tourniaire F, Astier J, Karkeni E, Canault M, Amiot MJ, et al. Vitamin D protects against diet-induced obesity by enhancing fatty acid oxidation. J Nutr Biochem. 2014;25:1077–83.

pubmed: 25052163 doi: 10.1016/j.jnutbio.2014.05.010

Fini M, Giavaresi G, Salamanna F, Veronesi F, Martini L, De Mattei M, et al. Harmful lifestyles on orthopedic implantation surgery: a descriptive review on alcohol and tobacco use. J Bone Miner Metab. 2011;29:633–44.

pubmed: 21898177 doi: 10.1007/s00774-011-0309-1

Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, et al. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res. 2008;1:17–29.

doi: 10.1359/jbmr.070813

Cao JJ. Effects of obesity on bone metabolism. J Orthop Surg Res. 2011;6:30–6.

pubmed: 21676245 pmcid: 3141563 doi: 10.1186/1749-799X-6-30

Williams FM, Spector TD. Recent advances in the genetics of osteoporosis. Musculoskelet Neuronal Interact. 2006;6:27–35.

Ji GR, Yao M, Sun CY, Li ZH, Han Z. BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and risk of fracture in Caucasians: a meta-analysis. Bone. 2010;47:681–6.

pubmed: 20601302 doi: 10.1016/j.bone.2010.06.024

Deng H, Liu F, Pan Y, Jin X, Wang H, Cao J. BsmI, TaqI, ApaI, and FokI polymorphisms in the vitamin D receptor gene and periodontitis: a meta-analysis of 15 studies including 1338 cases and 1302 controls. J Clin Periodontol. 2011;38:199–207.

pubmed: 21198767 doi: 10.1111/j.1600-051X.2010.01685.x

Li Y, Xi B, Li K, Wang C. Association between vitamin D receptor gene polymorphisms and bone mineral density in Chinese women. Mol Biol Rep. 2012;39:5709–17.

pubmed: 22193625 doi: 10.1007/s11033-011-1380-3

Marozik P, Mosse I, Alekna V, Rudenko E, Tamulaitienė M, Ramanau H, et al. Association between polymorphisms of VDR, COL1A1, and LCT genes and bone mineral density in Belarusian women with severe postmenopausal osteoporosis. Medicina (Kaunas). 2013;49:177–84.

pubmed: 23985982

Tarner IH, Erkal MZ, Obermayer-Pietsch BM, Hofbauer LC, Bergmann S, Goettsch C, et al. Osteometabolic and osteogenetic pattern of Turkish immigrants in Germany. Exp Clin Endocrinol Diabetes. 2012;120:517–23.

pubmed: 22956254 doi: 10.1055/s-0032-1321808

Kurt O, Yilmaz-Aydogan H, Uyar M, Isbir T, Seyhan MF, Can A. Evaluation of ERα and VDR gene polymorphisms in relation to bone mineral density in Turkish postmenopausal women. Mol Biol Rep. 2012;39:6723–30.

pubmed: 22311020 doi: 10.1007/s11033-012-1496-0

Pouresmaeili F, Jamshidi J, Azargashb E, Samangouee S. Association between vitamin D receptor gene BsmI polymorphism and bone mineral density in a population of 146 Iranian women. Cell J. 2013;15:75–82.

pubmed: 23700563 pmcid: 3660027

Khatkhatay MI. Genetic factors contributing to osteoporosis: study of vitamin D receptor polymorphism and estrogen receptor gene in Indian population. Hum Mol Genet. 2004;13:1633–9.

Thakkinstian A, Eisman J, Atteia J, Neygyen J. Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res. 2004;19:419–28.

pubmed: 15040830 doi: 10.1359/JBMR.0301265

Horst-Sikorska W, Ignaszak-Szczepaniak M, Marcinkowska M, Kaczmarek M, Stajgis M, Slomski R. Association analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves’ disease. Acta Biochim Pol. 2008;55:371–80.

pubmed: 18506225 doi: 10.18388/abp.2008_3085

Creatsa M, Pliatsika P, Kaparos G, Antoniou A, Armeni E, Tsakonas E, et al. The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: a pilot study. J Obstet Gynaecol Res. 2011;37:1415–22.

pubmed: 21651652 doi: 10.1111/j.1447-0756.2011.01557.x

Lisker R, López MA, Jasqui S, Ponce De León Rosales S, Correa-Rotter R, Sánchez S, et al. Association of vitamin D receptor polymorphisms with osteoporosis in Mexican postmenopausal women. Hum Biol. 2003;75:399–403.

pubmed: 14527203 doi: 10.1353/hub.2003.0045

Kiel DP, Demissie S, Dupuis J, Lunetta KL, Murabito JM, Karasik D. Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med Genet. 2007;19:S14.

doi: 10.1186/1471-2350-8-S1-S14

Mosaad YM, Hammadb EM, Fawzy Z, Abdal IA, Youssef HM, ElSaid TO, et al. Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis. Hum Immunol. 2014;75:452–61.

pubmed: 24530824 doi: 10.1016/j.humimm.2014.02.009

Hussien YM, Shehata A, Karam RA, Alzahrani SS, Magdy H, El-Shafey AM. Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. Mol Biol Rep. 2013;40:3675–80.

pubmed: 23271131 doi: 10.1007/s11033-012-2443-9

Jia F, Sun RF, Li QH, Wang DX, Zhao F, Li JM, et al. Vitamin D receptor BsmI polymorphism and osteoporosis risk: a meta-analysis from 26 studies. Genet Test Mol Biomarkers. 2013;17:30–4.

pubmed: 23134477 doi: 10.1089/gtmb.2012.0267

Qin G, Dong Z, Zeng P, Liu M, Liao X. Association of vitamin D receptor BsmI gene polymorphism with risk of osteoporosis: a meta-analysis of 41 studies. Mol Biol Rep. 2013;40:497–506.

pubmed: 23054016 doi: 10.1007/s11033-012-2086-x

Shen H, Xie J, Lu H. Vitamin D receptor gene and risk of fracture in postmenopausal women: a meta-analysis. Climacteric. 2014;17:319–24.

pubmed: 24156276 doi: 10.3109/13697137.2013.856401

Wu FY, Liu CS, Liao LN, Li CI, Lin CH, Yang CW, et al. Vitamin D receptor variability and physical activity are jointly associated with low handgrip strength and osteoporosis in community-dwelling elderly people in Taiwan: the Taichung Community Health Study for Elders (TCHS-E). Osteoporos Int. 2014;25:1917–29.

pubmed: 24682357 doi: 10.1007/s00198-014-2691-8

Lauridsen AL, Vestergaard P, Nexo E. Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem. 2001;47:753–6.

pubmed: 11274031 doi: 10.1093/clinchem/47.4.753

Lauridsen AL, Vestergaard P, Hermann AP, Moller HJ, Mosekilde L, Nexo E. Female premenopausal fracture risk is associated with Gc phenotype. J Bone Miner Res. 2004;19:875–81.

pubmed: 15125786 doi: 10.1359/JBMR.040133

Lauridsen AL, Vestergaard P, Hermann AP, Brot C, Heickendorff L, Mosekilde L, et al. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxyvitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int. 2005;77:15–22.

pubmed: 15868280 doi: 10.1007/s00223-004-0227-5

Pekkinen M, Saarnio E, Viljakainen HT, Kokkonen E, Jakobsen J, Cashman K, et al. Vitamin D binding protein genotype is associated with serum 25-hydroxyvitamin D and PTH concentrations, as well as bone health in children and adolescents in Finland. PLoS One. 2014;9:e87292.

pubmed: 24498064 pmcid: 3907502 doi: 10.1371/journal.pone.0087292

Xu XH, Xiong DH, Liu XG, Guo Y, Chen Y, Zhao J, et al. Association analyses of vitamin D-binding protein gene with compression strength index variation in Caucasian nuclear families. Osteoporos Int. 2010;21:99–107.

pubmed: 19543766 doi: 10.1007/s00198-009-0929-7

Taes YE, Goemaere S, Huang G, Van Pottelbergh I, De Bacquer D, Verhasselt B, et al. Vitamin D binding protein, bone status and body composition in community-dwelling elderly men. Bone. 2006;38:701–7.

pubmed: 16309986 doi: 10.1016/j.bone.2005.10.006

Al-oanzi ZH, Tuck SP, Mastana SS, Summers GD, Cook DB, Francis RM, et al. Vitamin D binding protein gene microsatellite polymorphism influences BMD and risk of fractures in men. Osteoporos Int. 2008;19:951–60.

pubmed: 18038108 doi: 10.1007/s00198-007-0516-8

Papiha SS, Allcroft LC, Kanan RM, Francis RM, Datta HK. Vitamin D binding protein gene in male osteoporosis: association of plasma DBP and bone mineral density with (TAAA)n-Alu polymorphism in DBP. Calcif Tissue Int. 1999;65:262–6.

pubmed: 10485974 doi: 10.1007/s002239900695

Speeckaert M, Huang G, Delanghe JR, Taes YE. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta. 2006;372:33–42.

pubmed: 16697362 doi: 10.1016/j.cca.2006.03.011

Thongthai P, Chailurkit LO, Chanprasertyothin S, Nimitphong H, Sritara P, Aekplakorn W, et al. Vitamin D binding protein gene polymorphism as a risk factor for vitamin D deficiency in Thais. Endocr Pract. 2015;21:221–5.

pubmed: 25370324 doi: 10.4158/EP14266.OR

Ezura Y, Nakajima T, Kajita M, Ishida R, Inoue S, Yoshida H, et al. Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density. J Bone Miner Res. 2003;18:1642–9.

pubmed: 12968673 doi: 10.1359/jbmr.2003.18.9.1642

Sinotte M, Diorio C, Bérubé S, Pollak M, Brisson J. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr. 2009;89:634–40.

pubmed: 19116321 doi: 10.3945/ajcn.2008.26445

Bu FX, Armas L, Lappe J, Zhou Y, Gao G, Wang HW, et al. Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. Hum Genet. 2010;128:549–56.

pubmed: 20809279 doi: 10.1007/s00439-010-0881-9

Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A. 2004;101:7711–5.

pubmed: 15128933 pmcid: 419671 doi: 10.1073/pnas.0402490101

Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010;19:2739–45.

pubmed: 20418485 pmcid: 2883344 doi: 10.1093/hmg/ddq155

Ramos-Lopez E, Kahles H, Weber S, Kukic A, Penna-Martinez M, Badenhoop K, et al. Gestational diabetes mellitus and vitamin D deficiency: genetic contribution of CYP27B1 and CYP2R1 polymorphisms. Diabetes Obes Metab. 2008;10:683–5.

pubmed: 18476984 doi: 10.1111/j.1463-1326.2008.00879.x

Massey K, Dickerson RN, Brown RO. A review of vitamin D deficiency in the critical care population. Pharmacy. 2014;2:40–9.

doi: 10.3390/pharmacy2010040

Vitamin D Level Between Calcium-Phosphorus Homeostasis and Immune System: New Perspective in Osteoporosis.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Pagination

Informations de copyright

Références

Auteurs

Daniele Bellavia (D)

Viviana Costa (V)

Angela De Luca (A)

Melania Maglio (M)

Stefania Pagani (S)

Milena Fini (M)

Gianluca Giavaresi (G)

Classifications MeSH